6505--VALBHCS Lymphoseek IDIQ

The Special Notice is a federal contract opportunity published by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VISN 22) on December 9, 2024. The notice concerns a procurement for Lymphoseek, a specialized radiopharmaceutical agent used for lymph node imaging prior to curative surgery. The contract is structured as an Indefinite Delivery Indefinite Quantity (IDIQ) agreement with Cardinal Health 414, LLC as the sole source provider. The procurement is specifically for the VA Long Beach Healthcare System Radiology Service, with a base period from January 1, 2025, through December 31, 2025, and four potential one-year option periods extending through December 31, 2029. The total requirement is for 20 units of Lymphoseek per year over the potential five-year contract period.

The primary objective of this Special Notice is to establish a sole-source contract for Lymphoseek, justified by Cardinal Health 414, LLC's exclusive patent rights to manufacture and distribute the drug in the United States. The response deadline is December 11, 2024, at 10:00 AM Pacific Time, with the solicitation number 36C26225Q0229. Market research through SBA's VetCert identified 133 Service-Disabled/Veteran-Owned Small Businesses (SD/VOSBs) under NAICS code 325412, but none could manufacture or distribute this proprietary drug. The technical justification emphasizes Lymphoseek's unique receptor-targeting capabilities (CD206 receptor), which provide superior imaging quality compared to alternative agents. The procurement falls under PSC 6505 (Drugs and Biologicals) and NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with the contracting office located in Long Beach, CA. This opportunity follows similar sole-source awards to Cardinal Health 414, LLC at other VISN 22 VA Medical Centers.